Susimaire P. Mantoani

Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors

Susimaire P. Mantoani, Talita P.C. Chierrito, Adriana Ferreira Lopes Vilela et al. · Molecules · 2016 · 59 citations · Full text

Virtual Screening Strategies in Drug Design

Ricardo Pereira Rodrigues, Susimaire P. Mantoani, Jonathan Almeida et al. · Revista Virtual de Química · 2012 · 41 citations · Full text

Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease

Peterson de Andrade, Susimaire P. Mantoani, Paulo Sérgio Gonçalves Nunes et al. · Bioorganic & Medicinal Chemistry · 2018 · 40 citations · Full text

Medicinal Chemistry, Alzheimer's Disease, Biochemistry +10

Using Free Computational Resources To Illustrate the Drug Design Process in an Undergraduate Medicinal Chemistry Course

Ricardo Pereira Rodrigues, Saulo Fernandes de Andrade, Susimaire P. Mantoani et al. · Journal of Chemical Education · 2015 · 31 citations

Drug Target, System Pharmacology, Drug Class +26

Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity

Paulo Sérgio Gonçalves Nunes, Gabriel da Silva, Sofia Nascimento et al. · Bioorganic Chemistry · 2021 · 16 citations

Medicinal Chemistry, Medicine, Antiproliferative Agents +9